These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37943350)

  • 21. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury.
    Iruzubieta P; Goikoetxea-Usandizaga N; Barbier-Torres L; Serrano-Maciá M; Fernández-Ramos D; Fernández-Tussy P; Gutiérrez-de-Juan V; Lachiondo-Ortega S; Simon J; Bravo M; Lopitz-Otsoa F; Robles M; Ferre-Aracil C; Varela-Rey M; Elguezabal N; Calleja JL; Lu SC; Milkiewicz M; Milkiewicz P; Anguita J; Monte MJ; Marin JJG; López-Hoyos M; Delgado TC; Rincón M; Crespo J; Martínez-Chantar ML
    JHEP Rep; 2021 Jun; 3(3):100276. PubMed ID: 33997750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bile duct ligation on bile acid composition in mouse serum and liver.
    Zhang Y; Hong JY; Rockwell CE; Copple BL; Jaeschke H; Klaassen CD
    Liver Int; 2012 Jan; 32(1):58-69. PubMed ID: 22098667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang.
    Yang Q; Yang F; Tang X; Ding L; Xu Y; Xiong Y; Wang Z; Yang L
    BMC Complement Altern Med; 2015 Apr; 15():122. PubMed ID: 25887351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive and Preferential Cellular Accumulation of Hydrophobic Bile Acids Induced by Cholestatic Drugs Is Associated with Inhibition of Their Amidation and Sulfation.
    Sharanek A; Burban A; Humbert L; Guguen-Guillouzo C; Rainteau D; Guillouzo A
    Drug Metab Dispos; 2017 Dec; 45(12):1292-1303. PubMed ID: 28928138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of glucuronidation for hepatic detoxification and urinary elimination of toxic bile acids during biliary obstruction.
    Perreault M; Białek A; Trottier J; Verreault M; Caron P; Milkiewicz P; Barbier O
    PLoS One; 2013; 8(11):e80994. PubMed ID: 24244729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in Circulating Bile Acids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis.
    Lai J; Luo L; Zhou T; Feng X; Ye J; Zhong B
    Biomolecules; 2023 Sep; 13(9):. PubMed ID: 37759756
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids.
    Yang T; Shu T; Liu G; Mei H; Zhu X; Huang X; Zhang L; Jiang Z
    J Steroid Biochem Mol Biol; 2017 Sep; 172():69-78. PubMed ID: 28583875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating bile acids predict outcome in critically ill patients.
    Horvatits T; Drolz A; Rutter K; Roedl K; Langouche L; Van den Berghe G; Fauler G; Meyer B; Hülsmann M; Heinz G; Trauner M; Fuhrmann V
    Ann Intensive Care; 2017 Dec; 7(1):48. PubMed ID: 28466463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism.
    Han Q; Yan X; Wang L; Zhang N; Zhang W; Li H; Chen W; You H; Yang A
    Biochem Biophys Res Commun; 2023 Nov; 682():259-265. PubMed ID: 37826949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultra-performance chromatography-electrospray tandem mass spectrometry analysis of bile acid profiles in the enterohepatic circulation following geniposide and acetaminophen-induced liver injury.
    Qin S; Tian J; Wang L; Zhao Y; Wang D; Wang F; Meng J; Liu M; Liang A
    J Chromatogr A; 2022 Sep; 1680():463417. PubMed ID: 35985151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes.
    Sharanek A; Burban A; Humbert L; Bachour-El Azzi P; Felix-Gomes N; Rainteau D; Guillouzo A
    Toxicol Sci; 2015 Oct; 147(2):573-87. PubMed ID: 26198044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases.
    Sanyal AJ; Ling L; Beuers U; DePaoli AM; Lieu HD; Harrison SA; Hirschfield GM
    JHEP Rep; 2021 Jun; 3(3):100255. PubMed ID: 33898959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The choleretic role of tauroursodeoxycholic acid exacerbates alpha-naphthylisothiocyanate induced cholestatic liver injury through the FXR/BSEP pathway.
    Zhao J; Song G; Weng F; Li Y; Zou B; Jin J; Yan D; Sun X; Liu C; Qiu FR
    J Appl Toxicol; 2023 Jul; 43(7):1095-1103. PubMed ID: 36787806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.
    Cabrera D; Arab JP; Arrese M
    Handb Exp Pharmacol; 2019; 256():237-264. PubMed ID: 31236688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism.
    Lu Y; Shao M; Zhang C; Xiang H; Wang J; Wu T; Ji G
    Front Pharmacol; 2022; 13():946360. PubMed ID: 36249786
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased intercellular adhesion molecule-1 serum concentration in cholestasis.
    Polzien F; Ramadori G
    J Hepatol; 1996 Dec; 25(6):877-86. PubMed ID: 9007716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience.
    Calabrò MG; Febres D; Recca G; Lembo R; Fominskiy E; Scandroglio AM; Zangrillo A; Pappalardo F
    Artif Organs; 2019 Feb; 43(2):189-194. PubMed ID: 30156308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aryl hydrocarbon receptor (AhR) mediated short-term effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on bile acid homeostasis in mice.
    Csanaky IL; Lickteig AJ; Klaassen CD
    Toxicol Appl Pharmacol; 2018 Mar; 343():48-61. PubMed ID: 29452137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colesevelam attenuates cholestatic liver and bile duct injury in
    Fuchs CD; Paumgartner G; Mlitz V; Kunczer V; Halilbasic E; Leditznig N; Wahlström A; Ståhlman M; Thüringer A; Kashofer K; Stojakovic T; Marschall HU; Trauner M
    Gut; 2018 Sep; 67(9):1683-1691. PubMed ID: 29636383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes.
    Marion TL; Perry CH; St Claire RL; Brouwer KL
    Toxicol Appl Pharmacol; 2012 May; 261(1):1-9. PubMed ID: 22342602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.